U.S. patent application number 16/733107 was filed with the patent office on 2020-04-30 for reduced-pressure dressing connection pads, systems, and methods.
The applicant listed for this patent is KCI Licensing, Inc.. Invention is credited to Richard Daniel John COULTHARD, Christopher Brian LOCKE, Timothy Mark ROBINSON.
Application Number | 20200129675 16/733107 |
Document ID | / |
Family ID | 44560643 |
Filed Date | 2020-04-30 |
![](/patent/app/20200129675/US20200129675A1-20200430-D00000.png)
![](/patent/app/20200129675/US20200129675A1-20200430-D00001.png)
![](/patent/app/20200129675/US20200129675A1-20200430-D00002.png)
![](/patent/app/20200129675/US20200129675A1-20200430-D00003.png)
![](/patent/app/20200129675/US20200129675A1-20200430-D00004.png)
![](/patent/app/20200129675/US20200129675A1-20200430-D00005.png)
United States Patent
Application |
20200129675 |
Kind Code |
A1 |
ROBINSON; Timothy Mark ; et
al. |
April 30, 2020 |
REDUCED-PRESSURE DRESSING CONNECTION PADS, SYSTEMS, AND METHODS
Abstract
Systems, methods, and connectors are provided that introduce a
working gas at certain times into a reduced-pressure dressing into
order to break or avoid vacuum locks in the conduits removing
fluids. In one instance, a reduced-pressure connector includes a
connector body for applying a reduced pressure to the tissue site.
The connector body is formed with a venting port, a body conduit,
and a receptacle to receive a reduced-pressure delivery conduit.
The reduced-pressure connector includes a flexible member coupled
to the connector body over the venting port. The flexible member is
formed with at least one venting aperture. The flexible member is
biased away from the venting port and is configured to collapse and
seal the venting port under a reduced pressure greater than a
threshold pressure. Other systems, apparatuses, and methods are
disclosed.
Inventors: |
ROBINSON; Timothy Mark;
(Shillingstone, GB) ; LOCKE; Christopher Brian;
(Bournemouth, GB) ; COULTHARD; Richard Daniel John;
(Verwood, GB) |
|
Applicant: |
Name |
City |
State |
Country |
Type |
KCI Licensing, Inc. |
San Antonio |
TX |
US |
|
|
Family ID: |
44560643 |
Appl. No.: |
16/733107 |
Filed: |
January 2, 2020 |
Related U.S. Patent Documents
|
|
|
|
|
|
Application
Number |
Filing Date |
Patent Number |
|
|
15205784 |
Jul 8, 2016 |
10556044 |
|
|
16733107 |
|
|
|
|
13852718 |
Mar 28, 2013 |
9427502 |
|
|
15205784 |
|
|
|
|
13044338 |
Mar 9, 2011 |
8430867 |
|
|
13852718 |
|
|
|
|
61313351 |
Mar 12, 2010 |
|
|
|
Current U.S.
Class: |
1/1 |
Current CPC
Class: |
A61M 2039/248 20130101;
Y10T 29/49863 20150115; A61M 1/0031 20130101; A61M 2205/3344
20130101; A61F 13/00068 20130101; A61M 1/0092 20140204; A61M 1/0023
20130101; A61M 35/30 20190501; A61M 1/0088 20130101; A61M 1/0027
20140204; A61F 2013/0028 20130101; A61F 13/0216 20130101; A61M
1/0037 20130101 |
International
Class: |
A61M 1/00 20060101
A61M001/00; A61F 13/00 20060101 A61F013/00; A61F 13/02 20060101
A61F013/02 |
Claims
1.-9. (canceled)
10. A method of manufacturing a reduced-pressure connector for
applying a reduced pressure to a tissue site through a sealing
member, the method comprising: forming a connector body; forming a
body conduit in the connector body having a first end and a second
end; forming a venting port in the connector body; coupling a
flexible member over the venting port; forming at least one venting
aperture in the flexible member; and biasing the flexible member
away from the venting port so that the flexible member is adapted
to collapse and seal the venting port under a reduced pressure
greater than a threshold reduced pressure.
11. The method of claim 10, wherein the flexible member further
comprises one or more membranes releasably covering the at least
one venting aperture for filtering contaminants from air
communicated through the at least one venting aperture.
12. The method of claim 10, further comprising forming a cover over
the flexible member for at least partially covering the at least
one venting aperture for controlling air flow through the at least
on venting aperture.
13. The method of claim 10, wherein the venting port communicates
directly with the body conduit.
14. The method of claim 10, wherein the first end of the body
conduit is adapted to fluidly couple to a reduced-pressure delivery
conduit that supplies reduced pressure, and the second end of the
body conduit is adapted to deliver reduced pressure to a
manifold.
15.-23. (canceled)
24. A system for treating a tissue site on a patient with reduced
pressure comprising: a manifold for disposing adjacent the tissue
site; a sealing member having a first side and a second side, the
second side for disposing adjacent the manifold and a portion of an
epidermis adjacent the tissue site, the sealing member having a
supply aperture and a port aperture; a reduced-pressure connector
comprising a connector body formed with a venting port and a body
conduit having a first end and a second end; and a dressing valve
coupled to the connector body, the dressing valve comprising: a
valve body having a chamber, at least one venting aperture, and a
venting port, a ball disposed within the chamber, a spring biasing
the ball towards a seat, wherein when the ball is against the seat
an opening of the venting port into the chamber is sealed and the
at least one venting aperture is sealed, and wherein the spring is
configured such that the ball overcomes the biasing of the spring
when exposed to a reduced pressure greater than a relief pressure
whereupon a working gas enters the at least one venting aperture
and is communicated to the venting port.
25. The system of claim 24, wherein the dressing valve is coupled
adjacent the venting port.
26. The system of claim 24, wherein the venting port is fluidly
coupled directly with the body conduit.
27. A valve for a reduced-pressure connector, the valve comprising:
a valve body configured to extend across a connector body of the
reduced-pressure connector, the valve body having a first end, a
second end, and a chamber; a seat coupled to the second end of the
valve body and closing the chamber, the seat having a venting
aperture configured to permit fluid communication with the a
sealing element disposed within the chamber; and a biasing element
disposed in the chamber and operatively coupled to the sealing
element, the biasing element configured to prevent fluid
communication across the venting aperture if a reduced pressure at
the first end of the valve body is less than a relief pressure and
to permit fluid communication across the venting aperture if the
reduced pressure at the first end of the valve body is greater than
the relief pressure.
28. The valve of claim 27, wherein the valve body further comprises
a venting port having a first end proximate to the first end of the
valve body and a second end proximate to the second end of the
valve body, the venting port configured to permit fluid
communication through the valve body.
29. The valve of claim 28, wherein the venting port and the chamber
provide separate fluid communication paths across the valve
body.
30. The valve of claim 28, wherein the biasing element biases the
sealing element against the seat, blocking the venting
aperture.
31. The valve of claim 27, wherein the valve body further comprises
an access aperture formed in the first end of the valve body.
32. The valve of claim 27, wherein the venting aperture comprises a
plurality of venting apertures.
33. The valve of claim 27, wherein the sealing element is
configured to seal to the seat.
34. The valve of claim 27, wherein the sealing element comprises a
ball.
35. The valve of claim 27, wherein the sealing element comprises a
piston.
36. The valve of claim 27, wherein the biasing element comprises a
spring.
37. The valve of claim 27, wherein the relief pressure comprises a
reduced pressure greater than about 120 mm Hg.
38. The valve of claim 27, further comprising a filter covering the
venting aperture.
Description
RELATED APPLICATIONS
[0001] The present invention is a Divisional of U.S. patent Ser.
No. 15/205,784, entitled "Reduced-Pressure Dressing Connection
Pads, Systems, and Methods," filed Jul. 8, 2016, which is a
Divisional of U.S. patent application Ser. No. 13/852,718, now U.S.
Pat. No. 9,427,502, entitled "Reduced-Pressure Dressing Connection
Pads, Systems, and Methods," filed Mar. 28, 2013, which is a
Continuation of U.S. patent application Ser. No. 13/044,338, now
U.S. Pat. No. 8,430,867, entitled "Reduced-Pressure Dressing
Connection Pads, Systems, and Methods," filed Mar. 9, 2011, which
claims the benefit, under 35 USC .sctn. 119(e), of the filing of
U.S. Provisional Patent Application Ser. No. 61/313,351, entitled
"Reduced-Pressure Dressing Connection Pads, Systems, and Methods,"
filed Mar. 12, 2010, which is incorporated herein by reference for
all purposes.
BACKGROUND
[0002] The present disclosure relates generally to tissue treatment
systems and more particularly to reduced-pressure connection pads,
systems, and methods.
[0003] Clinical studies and practice have shown that providing a
reduced pressure in proximity to a tissue site augments and
accelerates the growth of new tissue at the tissue site. The
applications of this phenomenon are numerous, but application of
reduced pressure has been particularly successful in treating
wounds. This treatment (frequently referred to in the medical
community as "negative pressure wound therapy," "reduced-pressure
therapy," or "vacuum therapy") provides a number of benefits, which
may include faster healing and increased formulation of granulation
tissue. Typically, reduced pressure is applied to tissue through a
porous pad or other manifolding device. The porous pad distributes
reduced pressure to the tissue and channels fluids that are drawn
from the tissue. The porous pad often is incorporated into a
dressing having other components that facilitate treatment.
SUMMARY
[0004] According to an illustrative embodiment, According to an
illustrative embodiment, a reduced-pressure connector for use with
a reduced-pressure system for treating a tissue site includes a
connector body for applying a reduced pressure to the tissue site
through a sealing member. The connector body is formed with a body
conduit for fluidly coupling to a reduced-pressure delivery conduit
that supplies reduced pressure and a venting port. The
reduced-pressure connector further includes a flexible member
coupled to the connector body over the venting port. The flexible
member is formed with at least one venting aperture. The flexible
member is biased away from the venting port and is configured to
collapse and seal the venting port under a reduced pressure greater
than a threshold reduced pressure.
[0005] According to another illustrative embodiment, a system for
treating a tissue site on a patient with reduced pressure includes
a manifold for disposing adjacent to the tissue site, a sealing
member, and a reduced-pressure connector. The sealing member has a
first side and a second, tissue-facing side. The second-tissue
facing side of the sealing member is for disposing adjacent the
manifold and a portion of the patient's epidermis. The sealing
member has a supply aperture and a port aperture. The
reduced-pressure connector is for coupling to the sealing member to
supply reduced pressure to the manifold. The reduced-pressure
connector includes a connector body formed with a body conduit
having a first end and a second end. The second end of the body
conduit is fluidly coupled to the supply aperture. The
reduced-pressure connector further includes a venting port formed
in the connector body for providing fluid communication with the
port aperture. The reduced-pressure connector also includes a
flexible member coupled to the connector body over the venting
port. The flexible member is formed with at least one venting
aperture. The flexible member is biased away from the venting port
and is configured to collapse to seal the venting port under a
reduced pressure greater than a threshold pressure. The system
further includes a reduced-pressure source in fluid communication
with the reduced-pressure connector through a reduced-pressure
delivery conduit. The flexible member returns to an extended
position in response to the reduced pressure being less than the
threshold pressure. When the flexible member is in the extended
position, the reduced-pressure connector is configured such that a
working gas from outside the flexible member is communicated
through the at least one venting aperture, venting port, and port
aperture to the tissue site for extraction by the body conduit for
alleviating a vacuum lock.
[0006] According to another illustrative embodiment, a method for
treating a tissue site on a patient with reduced pressure includes
deploying a manifold adjacent the tissue site and deploying a
sealing member over the manifold and a portion of the patient's
epidermis to form a sealed space. The sealing member has a port
aperture and a supply aperture. The method further includes
coupling a reduced-pressure connector to the sealing member to
provide reduced pressure to the sealed space. The reduced-pressure
connector includes a connector body having a venting port that is
fluidly coupled to the port aperture of the sealing member. The
method also includes fluidly coupling a reduced-pressure source to
the reduced-pressure connector. The reduced-pressure connector
includes the connector body formed with a body conduit having a
first end and a second end. The second end of the body conduit is
fluidly coupled to the supply aperture. The reduced-pressure
connector also includes a flexible member coupled to the connector
body over the venting port. The flexible member is formed with at
least one venting aperture. The flexible member is biased away from
the venting port and is configured to collapse to seal the venting
port under a reduced pressure greater than a threshold
pressure.
[0007] According to another illustrative embodiment, a method of
manufacturing a reduced-pressure connector for applying a reduced
pressure to a tissue site on a patient through a sealing member
includes forming a connector body and forming a body conduit in the
connector body having a first end and a second end. The first end
is for fluidly coupling to a reduced-pressure delivery conduit that
supplies reduced pressure and the second end is for delivering
reduced pressure to a manifold. The method also includes forming a
venting port in the connector body, coupling a flexible member to
the connector body over the venting port, and forming at least one
venting aperture in the flexible member. The flexible member is
biased away from the venting port and is configured to collapse and
seal the venting port under a reduced pressure greater than a
threshold reduced pressure.
[0008] According to another illustrative embodiment, a system for
treating a tissue site on a patient with reduced pressure includes
a manifold for disposing adjacent to the tissue site and a sealing
member having a first side and a second, tissue-facing side. The
second-tissue facing side is for disposing adjacent the manifold
and a portion of the patient's epidermis. The sealing member has a
supply aperture and a port aperture. The system also includes a
reduced-pressure connector having a connector body formed with a
venting port and a body conduit having a first end and a second
end. The reduced-pressure connector also includes a dressing valve
coupled to the connector body over the venting port. The dressing
valve includes a valve body having a chamber, at least one venting
aperture, and a venting port. The dressing valve further includes a
ball disposed within the chamber and a spring biasing the ball
towards a seat. When the ball is against the seat an opening of the
venting port into the chamber is sealed and the at least one
venting aperture is sealed. The spring is configured such that the
ball overcomes the biasing of the spring when exposed to a reduced
pressure greater than a relief pressure whereupon a working gas
enters the at least one venting aperture and is communicated to the
venting port.
[0009] According to another illustrative embodiment, a method for
preventing a vacuum lock during a reduced-pressure treatment of a
tissue site on a patient includes applying a reduced pressure to
the tissue site utilizing a treatment system to reach a reduced
pressure, sealing a dressing valve of the treatment system at a
first threshold pressure, and unsealing the dressing valve to
release a working gas into one or more venting apertures of the
dressing valve for extraction by a body conduit of the treatment
system to alleviate vacuum lock.
[0010] According to another illustrative embodiment, a method for
preventing a vacuum lock during a reduced-pressure treatment of a
tissue site on a patient includes applying a reduced pressure to
the tissue site at a reduced pressure utilizing a treatment system,
increasing the reduced pressure applied to the wound by the
treatment system, determining the reduced pressure applied to the
tissue site by the treatment system, venting a working gas through
a dressing valve of the treatment system to a reduced-pressure
delivery conduit in fluid communication with a reduced-pressure
source to alleviate any vacuum locks in response to determining
that the reduced pressure has reached a relief pressure, and
resealing the dressing valve.
[0011] Other features and advantages of the illustrative
embodiments will become apparent with reference to the drawings and
detailed description that follow.
BRIEF DESCRIPTION OF THE DRAWINGS
[0012] FIG. 1 is a schematic diagram with a portion shown in cross
section of a reduced-pressure treatment system in accordance with
an illustrative embodiment;
[0013] FIG. 2 is a top view of the reduced-pressure connector of
FIG. 1 in accordance with an illustrative embodiment;
[0014] FIG. 3 is a cross sectional view of the reduced-pressure
delivery conduit of FIG. 2 taken along line 3-3;
[0015] FIG. 4 is a cross sectional view of the reduced-pressure
connector of FIG. 1 shown with a dressing valve in an extended
position in accordance with an illustrative embodiment;
[0016] FIG. 5 is a cross sectional view of the reduced-pressure
connector of FIGS. 1 and 4 shown with the dressing valve in a
collapsed position in accordance with an illustrative
embodiment;
[0017] FIG. 6 is a graph illustrating pressure applied by the
reduced-pressure connector over time in accordance with an
illustrative embodiment (values on ordinate are negative);
[0018] FIG. 7 is a schematic diagram with a portion shown in cross
section of a reduced-pressure treatment system in accordance with
an illustrative embodiment;
[0019] FIG. 8 is a cross-sectional view of a dressing valve in
accordance with an illustrative embodiment; and
[0020] FIG. 9 is a graph illustrating pressure applied by the
reduced-pressure connector over time in accordance with an
illustrative embodiment;
DETAILED DESCRIPTION OF ILLUSTRATIVE EMBODIMENTS
[0021] In the following detailed description of the illustrative
embodiments, reference is made to the accompanying drawings that
form a part hereof. These embodiments are described in sufficient
detail to enable those skilled in the art to practice the
invention, and it is understood that other embodiments may be
utilized and that logical structural, mechanical, electrical, and
chemical changes may be made without departing from the spirit or
scope of the invention. To avoid detail not necessary to enable
those skilled in the art to practice the embodiments described
herein, the description may omit certain information known to those
skilled in the art. The following detailed description is,
therefore, not to be taken in a limiting sense, and the scope of
the illustrative embodiments are defined only by the appended
claims.
[0022] Referring primarily to FIGS. 1-5 and initially to FIG. 1, a
reduced-pressure treatment system 100 is shown. The
reduced-pressure treatment system 100 is utilized to treat a tissue
site 102. The tissue site 102 may be the bodily tissue of any
human, animal, or other organism including bone tissue, adipose
tissue, muscle tissue, dermal tissue, vascular tissue, connective
tissue, cartilage, tendons, ligaments, or any other tissue. Unless
otherwise indicated, "or" as used herein does not require mutual
exclusivity. The tissue site 102 may be a wound 104. The wound 104
may take numerous possible shapes and degrees, and in this
illustrative example is shown as a wound extending through
epidermis 106, dermis 108, and into subcutaneous tissue 110.
[0023] The reduced-pressure treatment system 100 may include a
manifold 112, a sealing member 114, and a reduced-pressure
connector 122. The reduced-pressure connector 122 includes a
connector body 123. The connector body 123 may have a body conduit
124 with a first end 126 and a second end 128. The first end 126
may be or include a receptacle 134. The receptacle 134 is for
receiving a reduced-pressure delivery conduit 129. The
reduced-pressure connector 122 also includes a dressing valve
136.
[0024] The term "manifold" as used herein generally refers to a
substance or structure that is provided to assist in applying
reduced pressure to, delivering fluids to, or removing fluids from
a tissue site 102. The manifold 112 typically includes a plurality
of flow channels or pathways that distribute fluids provided to and
removed from the tissue site 102 around the manifold 112. In one
illustrative embodiment, the flow channels or pathways are
interconnected to improve distribution of fluids provided or
removed from the tissue site 102. The manifold 112 may be a
biocompatible material that is capable of being placed in contact
with the tissue site 102 and distributing reduced pressure to the
tissue site 102. Examples of manifolds 112 may include, without
limitation, devices that have structural elements arranged to form
flow channels, such as, for example, cellular foam, open-cell foam,
porous tissue collections, liquids, gels, and foams that include,
or cure to include, flow channels. The manifold 112 may be porous
and may be made from foam, gauze, felted mat, or any other material
suited to a particular biological application. In one embodiment,
the manifold 112 is a porous foam and includes a plurality of
interconnected cells or pores that act as flow channels. The porous
foam may be a polyurethane, open-cell, reticulated foam such as
GranuFoam.RTM. material manufactured by Kinetic Concepts,
Incorporated of San Antonio, Tex. Other embodiments may include
"closed cells." In some situations, the manifold 112 may also be
used to distribute fluids such as medications, antibacterials,
growth factors, and various solutions to the tissue site 102. Other
layers may be included in or on the manifold 112, such as
absorptive materials, wicking materials, hydrophobic materials, and
hydrophilic materials.
[0025] In one illustrative, non-limiting embodiment, the manifold
112 may be constructed from bioresorbable materials that may remain
in a patient's body following use of the reduced-pressure treatment
system 100. Suitable bioresorbable materials may include, without
limitation, a polymeric blend of polylactic acid (PLA) and
polyglycolic acid (PGA). The polymeric blend may also include
without limitation polycarbonates, polyfumarates, and
capralactones. The manifold 112 may further serve as a scaffold for
new cell-growth, or a scaffold material may be used in conjunction
with the manifold 112 to promote cell-growth. A scaffold is a
substance or structure used to enhance or promote the growth of
cells or formation of tissue, such as a three-dimensional porous
structure that provides a template for cell growth. Illustrative
examples of scaffold materials include calcium phosphate, collagen,
PLA/PGA, coral hydroxy apatites, carbonates, or processed allograft
materials.
[0026] Any material or combination of materials may be used for the
manifold material provided that the manifold 112 is operable to
distribute the reduced pressure and allows the flow of fluids or
liquids. In some illustrative embodiments, the manifold 112 may
also be a combination or layering of materials. For example, a
first manifold layer of hydrophilic foam may be disposed adjacent
to a second manifold layer of hydrophobic foam to form the manifold
112.
[0027] Fluids may flow from the tissue site 102 through the
manifold 112, through a supply aperture 118 in the sealing member
114 into the body conduit 124. The fluids flow from the body
conduit 124 out of the receptacle 134 into the reduced-pressure
delivery conduit 129 and into a reduced-pressure source 132. The
reduced-pressure source 132 may include a chamber or reservoir for
receiving the fluids.
[0028] The reduced-pressure treatment system 100 includes the
sealing member 114. The sealing member 114 may include a supply
aperture 118 and a port aperture 120. The sealing member 114 is
fluidly coupled to the reduced-pressure connector 122. The sealing
member 114 covers the manifold 112 and typically extends past a
peripheral edge of the manifold 112 to form a drape extension 115.
The drape extension 115 may be sealed against the patient's
epidermis 106 by an attachment device 116.
[0029] An attachment device 116 may be used to hold the sealing
member 114 against the patient's epidermis 106 or another layer,
such as a gasket or additional sealing member. The attachment
device 116 may take numerous forms. For example, the attachment
device 116 may be a medically acceptable, pressure-sensitive
adhesive that extends about a periphery, a portion, or the entire
sealing member 114. As additional examples, the attachment device
116 may be a sealing tape, drape tape or strip, double-sided drape
tape, paste, hydrocolloid, hydro gel or other sealing devices or
elements.
[0030] If a tape is used the tape may be formed of the same
material as the sealing member 114 with a pre-applied pressure
sensitive adhesive. The adhesive may be applied on a tissue-facing,
or patient-facing side, of the sealing member 114. The sealing
member 114 and corresponding attachment device 116 provide a fluid
seal between the sealing member 114 and the epidermis 106 of the
patient. "Fluid seal," or "seal," means a seal adequate to maintain
reduced pressure at a desired site given the particular
reduced-pressure source 132 or subsystem involved. Before the
sealing member 114 is secured to the patient, the attachment device
116 may have removable strips covering the attachment device 116,
which are removed for treatment of the patient.
[0031] The sealing member 114 may be any material that provides a
fluid seal. The sealing member 114 may be, for example, an
impermeable or semi-permeable, elastomeric material. "Elastomeric"
means having the properties of an elastomer. Elastomeric material
generally refers to a polymeric material that has rubber-like
properties. More specifically, most elastomers have ultimate
elongations greater than 100% and a significant amount of
resilience. The resilience of a material refers to the material's
ability to recover from an elastic deformation. Examples of
elastomers may include, but are not limited to, natural rubbers,
polyisoprene, styrene butadiene rubber, chloroprene rubber,
polybutadiene, nitrile rubber, butyl rubber, ethylene propylene
rubber, ethylene propylene diene monomer, chlorosulfonated
polyethylene, polysulfide rubber, polyurethane (PU), EVA film,
co-polyester, and silicones. Additional, specific examples of
sealing member materials include a silicone drape, a 3M
Tegaderm.RTM. drape, or a polyurethane (PU) drape such as one
available from Avery Dennison Corporation of Pasadena, Calif.
[0032] All or portions of the reduced-pressure connector 122 may
also be formed from a polymer. The reduced-pressure connector 122
may be molded, cast, or otherwise generated from a single material
and molds or multiple materials and distinct molds. Additional
materials utilized alone or in combination to form all or portions
of the reduced pressure connector 122 may include polyurethane,
thermoplastic polyurethane, thermoplastic elastomers, silicone,
polyvinyl chloride, or other suitable materials.
[0033] The reduced-pressure source 132 provides reduced pressure.
The reduced-pressure source 132 may be any device for supplying a
reduced pressure, such as a vacuum pump, wall suction, micro-pump,
or other source. While the amount and nature of reduced pressure
applied to a tissue site will typically vary according to the
application, the reduced pressure will typically be between -5 mm
Hg and -500 mm Hg and more typically between -75 mm Hg and -300 mm
Hg. For example, and not by way of limitation, the pressure may be
-80, -90, -100, -110, -120, -130, -140, -150, -160, -170, -180,
-190, -200, -210 mm Hg or another pressure.
[0034] The reduced-pressure source 132 may include a display,
information indicator, battery light, reservoir, full or blocked
indicator, power switch, speaker, alarm system, keypad or any
number of other interfaces for receiving user input. In particular,
the reduced-pressure source 132 may be programmed or set to turn on
at one pressure or threshold and to turn off at another pressure or
secondary threshold. The thresholds may be set utilizing an
electronic user interface or utilizing mechanical regulation
elements. The reduced-pressure source 132 may provide reduced
pressure for a time period that is programmed by a user or
pre-programmed.
[0035] In one embodiment the reduced-pressure source 132 may
include one or more pressure sensors that may be utilized to detect
a pressure applied to the tissue site 102. For example, pressures
communicated by one or more lumens in the reduced-pressure delivery
conduit 129 may be sensed by the pressure sensors in the
reduced-pressure source 132 for governing the reduced pressure
applied. The reduced pressure supplied by the reduced-pressure
source 132 is delivered through the reduced-pressure delivery
conduit 129 to the reduced-pressure connector 122.
[0036] As used herein, "reduced pressure" generally refers to a
pressure less than the ambient pressure at a tissue site that is
being subjected to treatment. In most cases, this reduced pressure
will be less than the atmospheric pressure at which the patient is
located. Alternatively, the reduced pressure may be less than a
hydrostatic pressure at the tissue site. Reduced pressure may
initially generate fluid flow in the manifold 112, reduced-pressure
delivery conduit 129, and proximate the tissue site 102. As the
hydrostatic pressure around the tissue site 102 approaches the
desired reduced pressure, the flow may subside, and the reduced
pressure may be maintained. Unless otherwise indicated, values of
pressure stated herein are gauge pressures. The reduced pressure
delivered may be constant or varied (patterned or random) and may
be delivered continuously or intermittently. Although the terms
"vacuum" and "negative pressure" may be used to describe the
pressure applied to the tissue site, the actual pressure applied to
the tissue site may be more than the pressure normally associated
with a complete vacuum. Consistent with the use herein, unless
otherwise indicated, an increase in reduced pressure or vacuum
pressure typically refers to a relative reduction in absolute
pressure.
[0037] One or more devices 130 may be added to the reduced-pressure
delivery conduit. For example, the device 130 may be a fluid
reservoir, or collection member, to hold exudates and other fluids
removed. Other examples of devices 130 that may be included on the
reduced-pressure delivery conduit or otherwise fluidly coupled to
the reduced-pressure delivery conduit include the following
non-limiting examples: a pressure-feedback device, a volume
detection system, a blood detection system, an infection detection
system, a flow monitoring system, a temperature monitoring system,
or other device. Some of these devices may be formed integrally
with the reduced-pressure source 132.
[0038] In some cases, an extended fluid column in the body conduit
124, reduced-pressure delivery conduit 129, or elsewhere may
inhibit or prevent the removal of fluids. The situation may induce
a vapor lock (including a partial vapor lock). The vapor lock makes
fluid removal difficult. The vapor lock may also cause the reduced
pressure applied at the tissue site 102 to drop or be inhibited.
The reduced-pressure connector 122 described herein and the
associated dressing valve 136 may alleviate vapor lock by breaking
up or preventing columns of fluid.
[0039] The dressing valve 136 includes a flexible member 138, one
or more venting apertures 140, and a venting port 141. The dressing
valve 136 may be utilized to provide a working gas, e.g., air or
nitrogen, to the tissue site 102. The dressing valve 136 may also
communicate with a clean or dedicated source of working gas. For
example, the working gas may be a pressurized working gas, such as
a medical grade nitrogen supplied through a canister fluidly
communicating with the dressing valve 136 through the one or more
venting apertures 140.
[0040] The reduced-pressure connector 122 facilitates delivery of
reduced pressure through the sealing member 114 to a sealed space
that is formed under the sealing member 114. The reduced pressure
is delivered through the supply aperture 118 of the sealing member
114. The reduced pressure is further communicated to the venting
port 141 of the dressing valve 136 through the port aperture 120 of
the sealing member 114. The port aperture 120 and the venting port
141 may be aligned during deployment of the reduced-pressure
connector 122 on the sealing member 114. The body conduit 124 may
be similarly aligned with the supply aperture 118 of the sealing
member 114. In an alternative embodiment, an ancillary supply
conduit (not explicitly shown) may directly deliver reduced
pressure from the body conduit 124 to the dressing valve 136. The
ancillary supply conduit may be conduit formed in the connector
body 123 that fluidly couples the body conduit 124 and the interior
of the dressing valve 136. The opening of the ancillary supply
conduit into the interior of the dressing valve 136 in this
embodiment is the venting port 141.
[0041] In some circumstances, the body conduit 124 or the
reduced-pressure delivery conduit 129 may become blocked or
experience a vacuum lock. For example, a large amount of fluid may
create a vacuum lock within the body conduit 124 preventing the
removal of the fluids as well as application of the reduced
pressure to the tissue site 102. The dressing valve 136 may
function to alleviate (reduce or eliminate) the vacuum lock
associated with the reduced-pressure delivery conduit 129 and the
reduced-pressure source 132. The vacuum lock may also be referred
to as a fluid lock, vapor lock, air lock, or liquid lock.
[0042] The dressing valve 136 includes the venting port 141, a
flexible member 138, and the one or more venting apertures 140. The
port aperture 120 and venting port 141 provide fluid communication
between an interior of the dressing valve 136 and the manifold 112.
The flexible member 138 is a flexible cover that is biased away
from the port aperture 120. The collective area of the one or more
venting apertures 140 is typically less than the area of the
venting port 141. Upon being subjected to at least threshold
reduced pressure that is delivered to the interior of the dressing
valve 136, the flexible member 138 collapses and seals the port
aperture 120. The flexible member 138 may be integrated with the
connector body 123. For example, the connector body 123 and
flexible member 138 may be formed or molded as an integral member.
Alternatively, the flexible member 138 may be attached or coupled
to the connector body 123 utilizing adhesives, tape, a base unit
and locking mechanism, weld (RF or thermal), bond, cement, or
device or technique. As used herein, the term "coupled" includes
coupling via a separate object and includes direct coupling. The
term "coupled" also encompasses two or more components that are
continuous with one another by virtue of each of the components
being formed from the same piece of material. Also, the term
"coupled" may include chemical, such as via a chemical bond,
mechanical, thermal, or electrical coupling. Fluid coupling means
that fluid may be in communication between the designated parts or
locations.
[0043] The flexible member 138 is biased away from the venting port
141, but collapses to a retracted position (collapsed position) and
seals the venting port 141 as shown in FIG. 5. The flexible member
138 may be biased utilizing materials, springs, dampeners, or other
passive or active biasing elements to ensure that the port aperture
120 is not sealed unless the threshold reduced pressure is
experienced. Collapse as herein used may include bending, deforming
or otherwise moving to completely or partially seal the port
aperture 120. The reduced pressure at which the flexible member 138
seals off the venting port 141 may vary based on the thickness,
cross-sectional shape of the flexible member 138, the corresponding
material, the difference in area between the venting apertures 140
and the venting port 141, or other factors.
[0044] The flexible member 138 is formed to include the one or more
venting apertures 140. The venting apertures 140 may allow a
working gas to pass through the flexible member 138 into the
interior of the dressing valve 136. A working gas that passes
through the venting apertures 140 may be communicated through the
venting port 141 and port aperture 120 to the manifold 112 for
extraction through the body conduit 124.
[0045] The venting apertures 140 may include filters, membranes or
other similar elements (not shown) that may inhibit the entry of
bacteria, viruses or other airborne particles into the dressing
valve 136. The flexible member 138 may also include a cover that
may be turned, lifted or otherwise engaged to turn on, off, or
regulate the working gas flow through the venting apertures 140.
For example, the cover may be turned or moved to partially block
the working gas flow through the venting apertures 140.
[0046] Referring primarily now to FIG. 3, the reduced-pressure
delivery conduit 129 may include a primary lumen 302 and secondary
lumens 304. In one embodiment, the primary lumen 302 may be
utilized to extract fluids, such as exudates, from the tissue site
102 and apply the reduced pressure provided from the
reduced-pressure source 132. The secondary lumens 304 represent one
or more outer or ancillary lumens within the reduced-pressure
delivery conduit. For example, one or more of the secondary lumens
304 may measure the reduced pressure at the tissue site 102 by
allowing the reduced-pressure source 132 and corresponding pressure
sensors therein to measure the reduced pressure applied at the
tissue site 102 (or at the manifold 112, which should be at
approximately the same pressure as the tissue site 102). In
particular the primary lumen 302 and the secondary lumens 304
represent individual or isolated conduits that extend from the
reduced-pressure source 132 to the reduced-pressure connector 122
in order to apply and measure the reduced pressure as described
herein.
[0047] In another embodiment, the reduced-pressure delivery conduit
129 may include one or more wires, electrical cords for powering,
controlling or communicating electric signals between the
reduced-pressure source 132 and the reduced-pressure connector 122
or dressing valve 136. In an alternative embodiment, the dressing
valve 136 may be electronically actuated or controlled utilizing
control signals sent from the reduced-pressure source 132. For
example, the reduced-pressure source 132 may control the opening or
closing of the dressing valve 136 based on determined pressure
thresholds and using a solenoid. As a result, the dressing valve
136 may be opened, activated, or engaged to vent air to remove a
vacuum lock based on conditions, circumstances, or factors that may
indicate a vacuum lock has or is occurring within the
reduced-pressure system. In one embodiment, one of the secondary
lumens 304 may include the wire connected to a sensor or the
dressing valve 136. The secondary lumens 304 may allow the wire to
be extended therein for an electronic sensor or dressing valve
136.
[0048] Referring now primarily to FIG. 4, the reduced-pressure
connector 122 is shown with the flexible member 138 in a default,
biased, or extended position or state. The flexible member 138 may
be biased to urge the flexible member 138 away from the venting
port 141 when the reduced pressure on the interior of the flexible
member 138 is below a specified value or threshold pressure. The
pressure on the interior surface applied to the flexible member 138
is approximately the pressure experienced by the tissue site
102.
[0049] Bonds 402 may be used connect the flexible member 138 to the
connector body 123. For example, the bonds 402 may be glue, plastic
weld, ultrasonic or RF welds, cements, adhesives, mechanical
fasteners (such as clips, snaps, or other similar elements that
connect the flexible member 138 to the connector body 123 and
create a substantially airtight connection). As shown, the flexible
member 138 includes one or more venting apertures 140 which may
include multiple points allowing air from the surrounding
environment or another working gas to enter into the dressing valve
136. The one or more venting apertures 140 may be sized and shaped
to allow a specified amount of airflow through the flexible member
138 based on the venting needs of the reduced-pressure connector
122.
[0050] Referring now primarily to FIG. 5, the reduced-pressure
connector 122 is shown with the flexible member 138 collapsed to
seal the venting port 141. When collapsed (retracted), the flexible
member 138 allows the reduced pressure at the manifold 112 to
increase.
[0051] In another embodiment, the reduced-pressure connector 122
may include a lip (not shown) formed as an aspect of the connector
body 123. The lip may be formed to align with the periphery of the
venting port 141 in order to facilitate the flexible member 138
sealing the port aperture 120 when in the collapsed (retracted)
position.
[0052] Referring now primarily to FIGS. 1-5, in operation according
to one illustrative embodiment, the reduced-pressure treatment
system 100 is applied to treat the tissue site 102, e.g., the wound
104, by placing the manifold 112 adjacent the wound 104, providing
a fluid seal over the manifold 112 and a portion of the epidermis
106 by using the sealing member 114, attaching the reduced-pressure
connector 122, and activating the reduced-pressure source 132.
[0053] The reduced-pressure connector 122 delivers reduced pressure
to the manifold 112, which distributes the reduced pressure to the
tissue site 102. The reduced-pressure treatment system 100 will
typically continue to apply reduced pressure until a reservoir or
canister of the reduced-pressure source 132 or external reservoir
becomes full. The status of a reservoir or canister may be visually
or electronically monitored with alerts generated to inform a user
of a blockage or the canister or reservoir being filled.
[0054] The reduced-pressure source 132 applies reduced pressure to
the tissue site 102 and the dressing valve 136. Reduced pressure is
experienced on the interior or a portion of the flexible member 138
of the dressing valve 136. At a threshold reduced pressure, the
flexible member 138 collapses under the influence of reduced
pressure as shown in FIG. 5 to seal the venting port 141 thereby
allowing the reduced pressure to increase at the manifold 112 and
to remain unvented. The reduced-pressure source 132 may be
configured to turn off or maintain a specified reduced pressure.
For example, once the reduced-pressure source 132 has provided a
reduced pressure at the tissue site 102 for a set time or upon
reaching a desired pressure, the reduced-pressure source 132 may
turn itself off. Once the reduced pressure decreases (increases on
an absolute scale) to be lower than the threshold pressure, the
flexible member 138 returns to the open state or extended position
as shown in FIGS. 1 and 4, and the working gas enters the one or
more vent apertures 140. The addition of the working gas helps to
alleviate any vapor locks.
[0055] The dressing valve 136 as well as a control system of the
reduced-pressure source 132 may be utilized to control the reduced
pressure waveform applied to the tissue site 102. The waveform
indicates the time and reduced pressure provided by the
reduced-pressure source 132 and communicated to the
reduced-pressure connector 122. The dressing valve 136 may include
any number of venting apertures 140. For example, one or more
venting apertures 140 may be formed within the flexible member 138.
In another embodiment, the dressing valve 136 may not include
venting apertures 140, such as when the flexible member 138 may be
formed of a material that is semi-permeable to gases. As a result,
the semi-permeable material may allow air to seep through the
flexible member 138 at a known rate thereby fulfilling the
functions of the venting apertures 140 as described herein.
[0056] Referring now primarily to FIG. 6, a chart or graph
illustrating pressure applied by the reduced-pressure connector 122
over time is presented. In one embodiment, the reduced pressure may
be measured in mm Hg on the y (ordinate) axis and time in minutes
on the x (abscissa) axis. It should be noted that ordinate
indicates negative gauge pressure. The pressures and corresponding
time periods of FIG. 6 are shown for illustrative purposes only.
The reduced pressures applied through the reduced-pressure
treatment system 100 may vary as well as the time over which the
reduced pressures are incremented, decremented, or maintained.
[0057] Referring primarily to FIGS. 1 and 6, a chart 600 includes
various points that may correspond to utilization of the
reduced-pressure treatment system 100. In particular points A, B,
C, D, E and F of chart 600 may represent increases and decreases in
reduced pressure applied to the tissue site 102 based on positions
of the dressing valve 136. The example illustrated by chart 600
shows the initial pressure beginning at zero. A user, such as a
doctor, patient, nurse or other medical professional, may activate
the reduced-pressure source 132 at which point the reduced-pressure
source 132 may begin increasing the reduced pressure applied to the
reduced-pressure connector 122 and according to the tissue site
102.
[0058] Somewhere before point A (i.e., -120 mm Hg in this
embodiment), the threshold pressure is reached and the flexible
member 138 of the dressing valve 136 collapses to seal the venting
port 141 thereby preventing air from venting through the dressing
valve 136 to the tissue site 102. The threshold pressure may be,
for example, -90, -95, -100, -105, -110, or -115 mm Hg or another
pressure. At point A, the reduced-pressure source 132 determines
that the reduced-pressure treatment system 100 is at the desired
pressure (e.g., -125 mm Hg) or a higher or maximum threshold. The
desired pressure may be specified, selected, programmed or
otherwise configured for implementation by the reduced-pressure
source 132. Between point A and B the dressing valve 136 has been
sealed and the supply of reduced pressure has been terminated. The
flexible member 138 may remain collapsed thereby blocking the
venting port 141 from receiving air from the environment. Between
point A and B, the reduced pressure is applied to the tissue site
102 and corresponding wound 104 allowing the fluids to be drained
and providing the benefits of reduced pressure as currently known.
The reduced pressure applied to the tissue site 102 between points
A and B may naturally decrease as fluids are removed, based on
natural leakage, or based on venting introduced into the
reduced-pressure treatment system 100.
[0059] At point B the threshold pressure is reached and the
dressing valve 136 opens. For example, the bias inherent in the
flexible member 138 may overcome the reduced pressure exerted on
the flexible member 138 through the venting port 141 causing the
dressing valve 136 to reopen. At that point, the venting port 141
is opened and air or another working gas is vented through the
venting apertures 140 of the flexible member 138 through the port
aperture 120 of the sealing member 114 for extraction by the
reduced-pressure delivery conduit. In one embodiment, the dressing
valve 136 may be sealed and opened at approximately the same
reduced pressure, such as -110 mm Hg, -120 mm Hg, -130 mm Hg, or
another pressure.
[0060] As a result, the reduced pressure decreases significantly
between point B and point C as opposed to the natural or minimal
leakage that occurs between points A and B. At point C, the
reduced-pressure source 132 determines that the reduced pressure
has reached a minimum value and begins delivering reduced pressure
again. Alternatively or in addition, the reduced-pressure source
132 may be activated by a timer. Once the lower or minimum pressure
is reached or time duration reached, the reduced-pressure source
132 once again begins to apply reduced pressure to the tissue site
102 through the reduced-pressure connector 122. Points D, E and F
correspond to the actions previously described for points A, B, and
C, respectively. In another embodiment, the dressing valve 136 may
be configured to engage at a first threshold and disengage at
another threshold, which may control the time and pressures applied
to the tissue site. The reduced-pressure source 132 may be turned
on or off based on pressure applied, power utilized, or time
elapsed.
[0061] The determination of the reduced pressure applied to the
tissue site 102 may be performed utilizing any number of detection
sensors or measurement elements. For example, one or more secondary
conduits or lumens in the reduced-pressure delivery conduit 129 may
measure the reduced pressure. Alternatively, the reduced pressure
may be measured utilizing electronic sensors at the
reduced-pressure connector 122. The electronic sensors that may
measure conditions at the reduced-pressure connector 122 may
communicate with the reduced-pressure source 132 utilizing a wired
or a wireless connection. The cycles shown in FIG. 6 may be
repeated a number of times.
[0062] In other embodiments, the pressure applied at the respective
points may vary based on the treatment utilized for a particular
patient. For example, between point B and C, the reduced pressure
may decrease all the way to zero and remain there for a specified
time period before reactivating the reduced-pressure source 132.
Alternatively, the reduced pressure applied between point C and D
may be increased more slowly than was initially applied and to a
greater reduced pressure value.
[0063] Referring now primarily to FIGS. 7 and 8 another
illustrative embodiment of a reduced-pressure connector 722 in a
reduced-pressure treatment system 700 is presented. The
reduced-pressure connector 722 of FIGS. 7 and 8 is an alternative
embodiment. The reduced-pressure connector 722 includes a dressing
valve 736 that is operable to vent air from the environment to a
tissue site 702 in response to reaching a maximum, or elevated,
reduced pressure. The dressing valve 736 includes a valve body 870
having a chamber 871, at least one venting aperture 840, a venting
port 841, and a biasing member, such as spring 874. The dressing
valve 736 allows a working gas to flow through the dressing valve
736 into the tissue site 702 in response to a specified reduced
pressure being applied to the dressing valve 736.
[0064] The ball 872 may be formed from a plastic, metal, or a
composite material. The ball 872 is configured to move slidably or
roll up and down against the walls of the valve body 870 in the
chamber 871. In particular, the ball 872 may provide an airtight
seal between the ball 872 and a seat 873 of the valve body 870. The
ball experiences reduced pressure delivered through an access
aperture 876 regardless of the position of the ball 872 within the
dressing valve 736. The ball 872 may alternatively be any number of
sealing elements, such as a piston.
[0065] The spring 874 biases the ball 872 towards the seat 873.
When the ball 872 is against the seat 873, an opening 875 of the
venting port 841 into the chamber 871 is sealed and the at least
one venting aperture 840 is sealed. The spring 874 is configured
such that the ball 872 overcomes the biasing of the spring 874 when
exposed to a reduced pressure greater than the maximum reduced
pressure. Whereupon, a working gas enters the at least one venting
aperture 840 and is communicated to the venting port 841.
[0066] The dressing valve 736 may include one or more venting
apertures 840. At a regular or operating pressure, (e.g., -115 mm
Hg) the ball 872 is at the top (for the orientation shown) of the
dressing valve 736 in the seat 873 thereby sealing the venting
apertures 840 from communicating air from the environment through
the dressing valve 736. The spring 874 is a biased member that
supports the ball 872. The spring 874 may alternatively be an
elastomer, pneumatic or hydraulic element, or other biased element
that maintains the ball 872 at the top of the dressing valve 736 at
pressures below a threshold pressure.
[0067] The maximum pressure may represent a relief, or cracking
value. The reduced pressure applied to the tissue site 702 is
similarly applied to the dressing valve 736 and particularly to the
ball 872 through the aperture 876. The aperture 876 ensures that
the reduced pressures experienced underneath the reduced-pressure
connector 722 and sealing member 714 are similarly applied within
the dressing valve 736. For example, once the maximum pressure is
reached, the ball 872 compresses the spring 874 sufficiently to
allow air to be communicated through the venting apertures 840 to
the venting port 841 for communication to the tissue site 702. As a
result air or air bubbles may be introduced into the supply conduit
thereby reducing any vacuum locks and furthering assisting with the
removal of fluids or exudates from the tissue site 702. The
dressing valve 736 may require a specified reduced pressure, or
maximum reduced pressure to be applied against the ball 872 in
order to compress the spring 874. The aperture 876 and venting port
841 may be sized differently to ensure that the pressure against
the ball 872 is able to compress the spring 874. For example, the
aperture 876 may be multiple times the diameter of the venting port
841, such that greater pressure may be applied to the ball 872 to
reach the relief pressure. The venting port 841 may be configured
or positioned to enable vented air to be channeled to a supply
aperture 718.
[0068] As previously described, the venting apertures 840 may
include filters for filtering air from the environment in which the
reduced-pressure treatment system 700 is utilized. The dressing
valve 736 may utilize filters or membranes to maintain sterility
and prevent fluids from entering the dressing valve 736 through the
aperture 876 or venting port 841. The dressing valve 736 may
similarly be disengaged or deactivated utilizing a cover, switch or
other elements. For example, the venting apertures 840 may be
plugged or covered with a removable drape.
[0069] The illustrative embodiments may be utilized singly or in
combination to reduce or prevent vacuum lock when extracting fluids
from the tissue site 102. For example, elements of FIGS. 1-5, 7,
and 8 may be combined. In a first embodiment, the reduced-pressure
treatment system 100 may apply a reduced pressure to a wound site
utilizing a reduced-pressure source to extract fluid from the
tissue site 102. At a specified threshold or based on the
configuration of the dressing valve 136 incorporated with the
reduced-pressure treatment system 100, the dressing valve 136 is
sealed, and allows the reduced pressure to increase.
[0070] Next, the reduced-pressure treatment system 100 determines
whether the desired pressure is reached or a time period has
expired. If the desired pressure is not reached, the
reduced-pressure source 132 continues to increment the reduced
pressure applied to the reduced-pressure connector 122 and
corresponding tissue site 102. If the desired pressure is reached,
or a time period expires, the reduced-pressure source 132 is
deactivated. The determination of the desired pressure may be
determined by the reduced-pressure source 132 using the suction or
power applied, sensors, sensing lumens within the reduced-pressure
delivery conduit or any number of other detection elements or
sensors. The reduced-pressure source 132 ensures that the reduced
pressure applied to the tissue site 102 remains as stable as
possible once the reduced-pressure source 132 is deactivated.
[0071] The reduced-pressure treatment system 100 may begin to lose
pressure due to natural leaks. For example, air may seep through
edges of the sealing member 114 to enter the tissue site 102.
Alternatively, the materials of the reduced-pressure connector 122
and the sealing member 114 may be semi-permeable to air allowing
small amounts of air to naturally decrease the pressure applied to
the tissue site 102. In yet another embodiment, one or more of the
venting apertures 140 of the dressing valve 136 may communicate
directly with the supply aperture 118 allowing a small amount of
ambient air or a working gas to slowly break up a potential static
column of fluid. The air or working gas that is communicated
through the dressing valve 136 may be controlled and filtered to
prevent desiccation of the tissue site 102. Air introduced through
the dressing valve 136 may be filtered to ensure that contaminants
are not introduced to the tissue site 102 thereby causing infection
or other problems that may affect healing of the tissue site
102.
[0072] At a specified threshold, the dressing valve 136 becomes
unsealed and introduces additional air to the tissue site 102. The
air introduced through release of the dressing valve 136 or through
natural leakage may break up a static column of fluid causing a
vacuum lock or otherwise allow the fluids to be extracted through
the reduced-pressure delivery conduit 129 to the reduced-pressure
source 132 or a corresponding fluid housing, canister, or
reservoir. The specified threshold at which the dressing valve 136
becomes unsealed may correspond to the materials utilized for
forming the dressing valve 136. For example, in the case of the
flexible member 138, the thickness of the flexible member 138 may
govern when the dressing valve 136 both collapses to seal the
venting port 141 and unseals the venting port 141 to vent air to
the tissue site 102.
[0073] In response to reaching a desired minimum threshold pressure
or expiration of a time period, the reduced-pressure treatment
system 100 may once again apply a reduced pressure to the tissue
site 102 utilizing the reduced-pressure source 132. For example,
the reduced-pressure source 132 may be reactivated based on sensed
conditions. The reduced-pressure source 132 may simply utilize a
timer for turning on and off the reduced-pressure source 132.
[0074] The reduced-pressure treatment system 700 may apply a
reduced pressure to a tissue site 702 utilizing a reduced-pressure
source 732 to extract fluid from a tissue site 702. At pressures
utilized for treatment, the dressing valve 736 is sealed allowing
the reduced pressure to be maintained at the tissue site 702. In
response to a timer or other indication, the reduced pressure may
be increased. For example, every 10 minutes the reduced pressure
applied to the tissue site 702 may be increased by 50 mm Hg to
reach a maximum reduced pressure at which point the dressing valve
736 may release air through the venting port 841 to the tissue site
702 for extraction through the body conduit 724. The maximum
reduced pressure may be, for example and without limitation, -115,
-120, -130, -140, -150, -160, -170, -180, -190, -120 mm Hg or
another pressure. As a result, any fluids within the
reduced-pressure delivery conduit 729 and tissue site 702 may be
broken up by the introduction of air or working gas thereby
allowing the fluids to be more easily removed.
[0075] At the maximum threshold or relief pressure, the dressing
valve 736 opens introducing the working gas. The introduction of
working gas may cause the spring 874 to reseat the ball 872. At
that point, the reduced-pressure treatment system 700 returns to a
desired reduced pressure that corresponds to a standard treatment
pressure. The reduced pressure may be periodically incremented to
open the dressing valve 736 and thereby overcome static fluid
buildup or vacuum lock that may occur.
[0076] The reduced-pressure source 732 may include components that
determine whether a minimum threshold pressure has been reached.
The determination may be performed utilizing one or more lumens of
a reduced-pressure delivery conduit between the reduced-pressure
source 732 and the dressing valve 736. For example, a primary lumen
of the supply conduit may extract fluid from the tissue site 702,
and a secondary lumen may measure the reduced pressure applied to
the tissue site 702 by the reduced-pressure source 732. The
reduced-pressure source 732 continues to apply a reduced pressure
to the tissue site 702.
[0077] Referring now to FIGS. 7, 8, and 9, and primarily to FIG. 9,
a chart 900 presents pressure and time graph from use of the
reduced-pressure treatment system 700. The nature of the chart 900
is analogous to chart 600 in FIG. 6. The reduced-pressure treatment
system 700 may utilize the dressing valve 736 for releasing a
working gas through the reduced-pressure connector 722. In chart
900, the reduced pressure applied may begin at a level as shown
(i.e. -125 mm Hg). At point G, the reduced-pressure source may
begin to increase the reduced pressure until it reaches point H,
which is the maximum reduced pressure.
[0078] At point H, the dressing valve 736 may release air through
the venting port 841 to the reduced-pressure connector 722 to break
up or alleviate a vacuum lock. Point H represents a maximum or
cracking or relief pressure that engages the dressing valve 736 to
release air for reducing vacuum lock. Between points H and I, the
dressing valve 736 may allow air to be released through the venting
port 841.
[0079] At point I to J the reduced-pressure source 732 naturally or
mechanically reduces the reduced pressure until the original
pressure is reached at point J. Between points J and K, the reduced
pressure continues to be applied to the tissue site 702. The time
between the points in chart 900 may be controlled by timing
mechanisms within the reduced-pressure source 732. Alternatively,
logic, circuitry, processors, or sensors within the
reduced-pressure source 732 may increase or decrease the reduced
pressure to reach the relief pressure shown between points H and I
and L and M.
[0080] For example, the user may utilize an interface or mechanical
controls to configure the pressures and time between each point
based on the desired level and method of treatment. The relief
pressure that allows the body conduit to be released or partially
vented between points H and I and L and M may ameliorate a vacuum
lock. Similarly, the opening of the dressing valve in chart 600
between points B and C and E and F may provide similar
functionality.
[0081] The present invention and its advantages have been disclosed
in the context of certain illustrative, non-limiting embodiments.
The illustrative descriptions above are not intended to be
exhaustive or to limit the invention to the precise forms
disclosed. Moreover, it should be understood that various changes,
substitutions, permutations, and alterations can be made without
departing from the scope of the invention as defined by the
appended claims. It will be appreciated that any feature that is
described in a connection to any one embodiment may also be
applicable to any other embodiment. For example, without
limitation, the general statements related to the embodiments of
FIGS. 1-6 may apply to the embodiment of FIG. 7-8.
[0082] It will be understood that the benefits and advantages
described above may relate to one embodiment or may relate to
several embodiments. It will further be understood that reference
to `an` item refers to one or more of those items.
[0083] The steps of the methods described herein may be carried out
in any suitable order, or simultaneously where appropriate.
[0084] Where appropriate, aspects of any of the examples described
above may be combined with aspects of any of the other examples
described to form further examples having comparable or different
properties and addressing the same or different problems.
[0085] Where apparent from context, certain features of the devices
or systems are described "in use."
[0086] It will be understood that the above description of
preferred embodiments is given by way of example only and that
various modifications may be made by those skilled in the art. The
above specification, examples and data provide a complete
description of the structure and use of exemplary embodiments of
the invention. Although various embodiments of the invention have
been described above with a certain degree of particularity, or
with reference to one or more individual embodiments, those skilled
in the art could make numerous alterations to the disclosed
embodiments without departing from the scope of the claims.
* * * * *